Goin Kathleen 4
4 · PALVELLA THERAPEUTICS, INC. · Filed Mar 20, 2026
Research Summary
AI-generated summary of this filing
Palvella (PVLA) COO Kathleen Goin Exercises Options, Sells Shares
What Happened
- Kathleen Goin, Chief Operating Officer of Palvella Therapeutics (PVLA), exercised a total of 4,302 option-derived shares (2,154 at $7.14 and 2,148 at $9.08) on March 18, 2026 and sold all 4,302 shares in open-market transactions the same day.
- Exercise cost: ~$34,884 (2,154 x $7.14 = $15,380; 2,148 x $9.08 = $19,504). Sale proceeds: ~$507,611 (sales of 2,268, 1,730 and 304 shares at weighted averages of $117.56, $118.37 and $119.08). Net proceeds before fees/taxes: roughly $472,727.
- These were option exercises followed by same-day sales (effectively a cashless exercise and sale), which is typically a routine liquidity event rather than a directional purchase.
Key Details
- Transaction date: March 18, 2026; Form 4 filed March 20, 2026 (timely).
- Actions reported: M = exercise/conversion of derivative (4,302 shares acquired); S = open-market sales (4,302 shares disposed).
- Sale price details (weighted averages / ranges):
- 2,268 shares sold at weighted avg $117.56 (prices ranged $116.995–$117.99).
- 1,730 shares sold at weighted avg $118.37 (prices ranged $118.00–$118.81).
- 304 shares sold at weighted avg $119.08 (prices ranged $119.08–$119.3767).
- Footnotes: Transactions were executed under a Rule 10b5-1 trading plan adopted Aug 19, 2025 and occurred during an open trading window; the options were fully vested.
- Shares owned after the transactions: not specified in the filed Form 4.
Context
- For retail investors: this filing reflects an insider exercising vested options and selling the resulting shares the same day — a common way executives realize option value and meet tax or diversification needs. Because the trades were done under a pre-established 10b5-1 plan and the options were fully vested, these sales are presented as routine rather than a fresh bullish purchase signal.
- No indication of gifts, new awards, or 10% ownership changes in this filing.
Insider Transaction Report
Form 4
Goin Kathleen
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-03-18$7.14/sh+2,154$15,380→ 2,154 total - Exercise/Conversion
Common Stock
[F1]2026-03-18$9.08/sh+2,148$19,504→ 4,302 total - Sale
Common Stock
[F1][F2]2026-03-18$117.56/sh−2,268$266,633→ 2,034 total - Sale
Common Stock
[F1][F3]2026-03-18$118.37/sh−1,730$204,777→ 304 total - Sale
Common Stock
[F1][F4]2026-03-18$119.08/sh−304$36,201→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F5]2026-03-18−2,154→ 15,089 totalExercise: $7.14Exp: 2029-10-29→ Common Stock (2,154 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F5]2026-03-18−2,148→ 15,036 totalExercise: $9.08Exp: 2030-10-14→ Common Stock (2,148 underlying)
Footnotes (5)
- [F1]The transactions reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on August 19, 2025. The plan was adopted during an open trading window, at a time when the Reporting Person was not in possession of material non-public information and was reviewed and approved in accordance with the Issuer's Insider Trading Policy. The Issuer's officers and directors from time to time utilize trading plans to transact in its securities for reasons such as satisfying vesting-related income tax requirements, investment diversification, or other personal reasons.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.995 to $117.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.00 to $118.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $119.08 to $119.3767, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F5]The stock option is fully vested.
Signature
/s/ Kathleen A. McGowan, Attorney-in-Fact|2026-03-20